Novartis Bioventures Ltd Insider Profile
4 Followers
Novartis Bioventures Ltd, Former 10% Owner at Obsidian Therapeutics, holds 1.18M shares in AKOUOS (Ticker: AKUS), holds 2.47M shares in Obsidian Therapeutics (Ticker: OBX), holds 4.05M shares in Whitehawk Therapeutics (Ticker: WHWK).
Novartis Bioventures Ltd's Trading History
| AKUSAKOUOS | Jul 02, 2020 | ― | Uninformative Buy | ― | $15.70M | |
| OBXObsidian Therapeutics | Jun 22, 2020 | Former 10% Owner | Informative Sell | 8.27M | $30.13M | |
| BCYCBicycle Therapeutics | May 30, 2019 | Ten Percent Owner | Uninformative Buy | ― | $5.50M | |
| WHWKWhitehawk Therapeutics | Apr 29, 2019 | Ten Percent Owner | Informative Sell | 722.85K | $12.68M | |
| RNTXRein Therapeutics | Apr 02, 2019 | Ten Percent Owner | Informative Sell | 236.26K | $738.18K | |
| ALTAltimmune | Sep 14, 2018 | Ten Percent Owner | Uninformative Buy | ― | $11.60M | |
| SYRESpyre Therapeutics | May 14, 2018 | Ten Percent Owner | Informative Sell | 196.67K | $220.71M | |
| ELDNEledon Pharmaceuticals | Jul 17, 2015 | Ten Percent Owner | Informative Sell | 50.82K | $9.12M | |
| AKBAAkebia Therapeutics | Mar 27, 2014 | Ten Percent Owner | Uninformative Buy | ― | $74.50K | |
| EIGRQEiger Biopharmaceuticals | Feb 06, 2014 | ― | Informative Buy | 275.24K | $13.19M | |
| KANTKineta | ― | ― | ― | $629.59K |
You May Also Like
Novartis Bioventures Ltd insider profile FAQ
What is the percentage of profitable transactions made by Novartis Bioventures Ltd?
The percentage of profitable transactions made by Novartis Bioventures Ltd is 84%.
What is the average return per transaction made by Novartis Bioventures Ltd?
The average return per transaction made by Novartis Bioventures Ltd is 45.10%.
What stocks does Novartis Bioventures Ltd hold?
Novartis Bioventures Ltd holds: OBX, ALT, KANT, SYRE, ELDN, RNTX, WHWK, BCYC, AKUS, AKBA, EIGRQ stocks.
What was Novartis Bioventures Ltd's most profitable transaction?
Novartis Bioventures Ltd’s most profitable transaction was an Informative Buy of EIGRQ stock on February 6, 2014. The return on the trade was 103.10%.
What is Novartis Bioventures Ltd's role in Obsidian Therapeutics?
Novartis Bioventures Ltd's role in Obsidian Therapeutics is Former 10% Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
